Want to join the conversation?
$ISRG said that in 2015 its global procedure growth was about 14%, led by growth in general surgery, growth in the use of da Vinci Surgical Systems outside the U.S. and strength in urology. During 2015, U.S. general surgery growth was about 31%, made up of strong growth in inguinal hernia repair, ventral hernia repair, and colorectal surgery.
Apple ($AAPL) reported decline in sales and profits from comparable quarter last year, attributing the decline to announcement of iPhone 7/7s. Sales and profit are being guided higher for next quarter. Apple is a solid company and will continue to dominate tech and consumer electronics segment for a while. Personally, looks like there is little downside in this investment.
Waiting with fingers crossed for $AAPL’s fourth quarter earnings.
Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."